Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00450944
Title Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Albert Einstein College of Medicine
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.